Phase i dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies

Carlos R. Becerra, Udit N. Verma, Hia T. Tran, Denise Tavana, Noelle S. Williams, Eugene P. Frenkel

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences